Ababneh M, Ferreira HL, Khalifeh M, Suarez DL, Afonso CL, (2018). First genome sequence of Newcastle disease virus of genotype VIIi from Jordan. Microbiology Resource Announcements 7.
Abolnik C, Mubamba C, Wandrag DB, Horner R, Gummow B, Dautu G, Bisschop SP, (2018). Tracing the origins of genotype VII h Newcastle disease in Southern Africa. Transboundary and emerging diseases 65, e393-e403.
Alders RG, (2014). Making Newcastle disease vaccines available at village level. Veterinary Record 174, 502-503.
Barlow DJ, Edwards MS, Thornton JM, (1986). Continuous and discontinuous protein antigenic determinants. Nature 322, 747-748.
Boursnell M, Green P, Samson A, Campbell J, Deuter A, Peters R, Millar N, Emmerson P, Binns M, (1990). A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge NDV. Virology 178, 297-300.
Chambers P, Nesbit M, Yusoff K, Millar N, Samson A, Emmerson P, (1988). Location of a neutralizing epitope for the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. Journal of general virology 69, 2115-2122.
Chellappa MM, Dey S, Gaikwad S, Kataria J, Vakharia V, 2012. Complete genome sequence of Newcastle disease virus mesogenic vaccine strain R2B from India. Am Soc Microbiol.
Chen L, Gorman JJ, McKimm-Breschkin J, Lawrence LJ, Tulloch PA, Smith BJ, Colman PM, Lawrence MC, (2001). The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. Structure 9, 255-266.
Crennell S, Takimoto T, Portner A, Taylor G, (2000). Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nature structural biology 7, 1068-1074.
Dey S, Chellappa MM, Gaikwad S, Kataria JM, Vakharia VN, (2014). Genotype characterization of commonly used Newcastle disease virus vaccine strains of India. PLoS One 9, e98869.
Dimitrov KM, Abolnik C, Afonso CL, Albina E, Bahl J, Berg M, Briand F-X, Brown IH, Choi K-S, Chvala I, (2019). Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus. Infection, Genetics and Evolution 74, 103917.
Dimitrov KM, Afonso CL, Yu Q, Miller PJ, (2017). Newcastle disease vaccines—A solved problem or a continuous challenge? Veterinary microbiology 206, 126-136.
Dortmans JC, Peeters BP, Koch G, (2012). Newcastle disease virus outbreaks: vaccine mismatch or inadequate application? Veterinary microbiology 160, 17-22.
Fuller C, Löndt B, Dimitrov K, Lewis N, van Boheemen S, Fouchier R, Coven F, Goujgoulova G, Haddas R, Brown I, (2017). An epizootiological report of the re‐emergence and spread of a lineage of virulent Newcastle disease virus into Eastern Europe. Transboundary and emerging diseases 64, 1001-1007.
Ghalyanchilangeroudi A, Hosseini H, Jabbarifakhr M, Fallah Mehrabadi MH, Najafi H, Ghafouri SA, Mousavi FS, Ziafati Z, Modiri A, (2018). Emergence of a virulent genotype VIIi of Newcastle disease virus in Iran. Avian Pathology 47, 509-519.
Gong Y, Cui Z, (2011). Epitope variation in the Newcastle disease virus HN gene under antibody immune selective pressure in cell culture. Science China Life Sciences 54, 474-479.
Gorman J, Nestorowicz A, Mitchell SJ, Corino GL, Selleck PW, (1988). Characterization of the sites of proteolytic activation of Newcastle disease virus membrane glycoprotein precursors. Journal of Biological Chemistry 263, 12522-12531.
Gu M, Liu W, Xu L, Cao Y, Yao C, Hu S, Liu X, (2011). Positive selection in the hemagglutinin-neuraminidase gene of Newcastle disease virus and its effect on vaccine efficacy. Virology journal 8, 150.
Heo L, Park H, Seok C, (2013). GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Res 41, W384-388.
ICTV, (2019). International committee on taxonomy of viruses. Virus Taxonomy.
Iorio RM, Glickman RL, Sheehan JP, (1992). Inhibition of fusion by neutralizing monoclonal antibodies to the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. Journal of general virology 73, 1167-1176.
Iorio RM, Syddall RJ, Sheehan JP, Bratt MA, Glickman RL, Riel AM, (1991). Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition. Journal of virology 65, 4999-5006.
Jeon W-J, Lee E-K, Lee Y-J, Jeong O-M, Kim Y-J, Kwon J-H, Choi K-S, (2008). Protective efficacy of commercial inactivated Newcastle disease virus vaccines in chickens against a recent Korean epizootic strain. Journal of veterinary science 9, 295-300.
Khattar SK, Yan Y, Panda A, Collins PL, Samal SK, (2009). A Y526Q mutation in the Newcastle disease virus HN protein reduces its functional activities and attenuates virus replication and pathogenicity. Journal of virology 83, 7779-7782.
Kim S-H, Wanasen N, Paldurai A, Xiao S, Collins PL, Samal SK, (2013). Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine. PloS one 8, e74022.
Kumar S, Stecher G, Li M, Knyaz C, Tamura K, (2018). MEGA X: molecular evolutionary genetics analysis across computing platforms. Molecular biology and evolution 35, 1547-1549.
Lee Y-J, Sung H-W, Choi J-G, Lee E-K, Yoon H, Kim J-H, Song C-S, (2008). Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutinin-neuraminidase proteins. Journal of Veterinary Science 9, 301-308.
Liu J, Zhu J, Xu H, Li J, Hu Z, Hu S, Wang X, Liu X, (2017). Effects of the HN antigenic difference between the vaccine strain and the challenge strain of Newcastle Disease virus on virus shedding and transmission. Viruses 9, 225.
Merz DC, Scheid A, Choppin P, (1980). Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. The Journal of experimental medicine 151, 275-288.
Miller PJ, Afonso CL, El Attrache J, Dorsey KM, Courtney SC, Guo Z, Kapczynski DR, (2013). Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses. Developmental & Comparative Immunology 41, 505-513.
Miller PJ, Estevez C, Yu Q, Suarez DL, King DJ, (2009). Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses. Avian diseases 53, 39-49.
Miller PJ, King DJ, Afonso CL, Suarez DL, (2007). Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 25, 7238-7246.
Moult J, Fidelis K, Kryshtafovych A, Schwede T, Tramontano A, (2018). Critical assessment of methods of protein structure prediction (CASP)—Round XII. Proteins: Structure, Function, and Bioinformatics 86, 7-15.
Naohiro K, Masahiro N, Mitsuru O, Chieko K, Yoshiharu M, Takeshi M, (1994). Protective effect of individual glycoproteins of Newcastle disease virus expressed in insect cells: the fusion protein derived from an avirulent strain had lower protective efficacy. Virus research 32, 373-379.
Neyt C, Geliebter J, Slaoui M, Morales D, Meulemans G, Burny A, (1989). Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies. Journal of virology 63, 952-954.
Ponomarenko J, Bui HH, Li W, Fusseder N, Bourne PE, Sette A, Peters B, (2008). ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics 9, 514.
Reynolds D, Maraqa A, (2000). Protective immunity against Newcastle disease: the role of antibodies specific to Newcastle disease virus polypeptides. Avian diseases, 138-144.
Römer-Oberdörfer A, Veits J, Werner O, Mettenleiter TC, (2006). Enhancement of pathogenicity of Newcastle disease virus by alteration of specific amino acid residues in the surface glycoproteins F and HN. Avian diseases 50, 259-263.
Römer-Oberdörfer A, Werner O, Veits J, Mebatsion T, Mettenleiter TC, (2003). Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity. Journal of General Virology 84, 3121-3129.
Roy A, Kucukural A, Zhang Y, (2010). I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5, 725-738.
Sali A, Blundell TL, (1993). Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234, 779-815.
Shahar E, Haddas R, Goldenberg D, Lublin A, Bloch I, Bachner Hinenzon N, Pitcovski J, (2018). Newcastle disease virus: is an updated attenuated vaccine needed? Avian Pathology 47, 467-478.
Suarez DL, Miller PJ, Koch G, Mundt E, Rautenschlein S, (2020). Newcastle disease, other avian paramyxoviruses, and avian metapneumovirus infections. Diseases of poultry, 109-166.
Toyoda T, Gotoh B, Sakaguchi T, Kida H, Nagai Y, (1988). Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization. Journal of virology 62, 4427-4430.
Van Regenmortel MHV, (1996). Mapping Epitope Structure and Activity: From One-Dimensional Prediction to Four-Dimensional Description of Antigenic Specificity. Methods 9, 465-472.
Wiederstein M, Sippl MJ, (2007). ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35, W407-410.
Yang H-m, Zhao J, Xue J, Yang Y-l, Zhang G-z, (2017). Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV. Vaccine 35, 27-32.
Yusoff K, Nesbit M, McCartney H, Meulemans G, Alexander D, Collins M, Emmerson P, Samson A, (1989). Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C. Journal of general virology 70, 3105-3109.